TegoScience Inc (191420) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.025x

Based on the latest financial reports, TegoScience Inc (191420) has a cash flow conversion efficiency ratio of -0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.24 Billion ≈ $-842.30K USD) by net assets (₩50.33 Billion ≈ $34.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

TegoScience Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how TegoScience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read TegoScience Inc (191420) total liabilities for a breakdown of total debt and financial obligations.

TegoScience Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TegoScience Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Loulis Mills S.A. AT:KYLO	0.049x
TY Holdings Co Ltd KO:363280	0.004x
Song Shang Electronics Co Ltd TWO:6156	0.114x
Top Systems-L TA:TOPS	0.143x
Lark Distilling Co. Ltd AU:LRK	-0.002x
Artemis Hali As IS:ARTMS	0.009x
L.P.N. Development Public Company Limited BK:LPN	0.018x
HS Valve Co. Ltd KQ:039610	0.001x

Annual Cash Flow Conversion Efficiency for TegoScience Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of TegoScience Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of TegoScience Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩50.33 Billion ≈ $34.11 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.061x	-162.02%
2024-12-31	₩49.86 Billion ≈ $33.79 Million	₩-1.16 Billion ≈ $-785.84K	-0.023x	-35.59%
2023-12-31	₩46.33 Billion ≈ $31.39 Million	₩-794.61 Million ≈ $-538.49K	-0.017x	-180.12%
2022-12-31	₩48.60 Billion ≈ $32.93 Million	₩1.04 Billion ≈ $705.01K	0.021x	+126.95%
2021-12-31	₩48.47 Billion ≈ $32.85 Million	₩457.25 Million ≈ $309.87K	0.009x	-63.89%
2020-12-31	₩48.99 Billion ≈ $33.20 Million	₩1.28 Billion ≈ $867.16K	0.026x	+2916.76%
2019-12-31	₩47.82 Billion ≈ $32.41 Million	₩41.40 Million ≈ $28.06K	0.001x	-95.15%
2018-12-31	₩46.68 Billion ≈ $31.63 Million	₩833.88 Million ≈ $565.11K	0.018x	-77.74%
2017-12-31	₩35.71 Billion ≈ $24.20 Million	₩2.87 Billion ≈ $1.94 Million	0.080x	-11.57%
2016-12-31	₩25.98 Billion ≈ $17.61 Million	₩2.36 Billion ≈ $1.60 Million	0.091x	-13.13%
2015-12-31	₩25.21 Billion ≈ $17.08 Million	₩2.63 Billion ≈ $1.78 Million	0.104x	--

About TegoScience Inc

KQ:191420 Korea Pharmaceuticals

Market Cap

$68.13 Million

₩100.53 Billion KRW

Market Cap Rank

#20673 Global

#1244 in Korea

Share Price

₩12450.00

Change (1 day)

-1.03%

52-Week Range

₩11620.00 - ₩19790.00

All Time High

₩71600.00